On Thursday, Aug. 19, federal authorities announced a $1.9 billion makeover of the system for identifying and manufacturing drugs and vaccines for public health emergencies. The overhaul includes manufacturing refinements aimed at shaving weeks off the time it takes to produce pandemic flu vaccine and a series of steps aimed at more quickly detecting promising scientific discoveries and getting them to market.
For more information, read The Seattle Times’ article.
$1.9 Billion to Develop Medical Countermeasures Against Bioterrorism Threats
By: News Report on August 20, 2010
Latest Blog Posts 
Emergency Management Is a Complicated ProfessionFeb 11 It is no longer possible for one person to know everything about emergency management.…
Relationships are key--before the disasterFeb 11 Neil Clement's story below says it all about having important relationships in place before an event.…
Tweet breaking news? How news organizations are struggling with thisFeb 09 Great tips on how to manage social media, website, releases…
Featured Articles
America’s Crumbling Infrastructure Will Challenge Emergency Managers For Decades By: Adam Stone Jan 30, 2012